Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system

Journal of Infectious Diseases

Volumn 197, Issue 6, 2008, Pages 906-915

  Garzoni, Luciana Ribeiro ^a,c   Adesse, Daniel ^a   Soares, Maurilio José ^a,b   Rossi, Maria Isabel Doria ^a   Borojevic, Radovan ^a   De Meirelles, Maria De Nazareth Leal ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto de Biologia Molecular do Parana   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CELL VOLUME; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; HEART CELL CULTURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTOZOAL INFECTION; SPHEROID CELL; TRYPANOSOMA CRUZI;

ANIMALS; CERCOPITHECUS AETHIOPS; CHAGAS CARDIOMYOPATHY; EXTRACELLULAR MATRIX; FIBROSIS; MICE; MYOCYTES, CARDIAC; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 40949165427     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/528373     Document Type: Article

References (36)

1. Swynghedauw B. Phenotypic plasticity of adult myocardium: molecular mechanisms. J Exp Biol 2006; 209:2320-7.
2. De Souza W. Chagas' disease: facts and reality. Microbes Infect 2007; 9:544-5.
3. Higuchi ML, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003; 60:96-107.
4. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000; 102:3003-8.
5. Petersen CA, Krumholz KA, Burleigh BA. Toll-like receptor 2 regulates interleukin-1 beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun 2005; 73:6974-80.
6. Waghabi MC, Keramidas M, Feige JJ, Araujo-Jorge TC, Bailly S. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell Microbiol 2005; 7:511-7.
7. Tarleton RL. Parasite persistence in the aetiology of Chagas' disease. Int J Parasitol 2001; 31:550-4.
8. Leon JS, Engman DM. Autoimmunity in Chagas heart disease. Int J Parasitol 2001; 31:555-61.
9. Brener Z, Gazzinelli RT. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997; 114:103-10.
10. Meirelles MN, de Araujo-Jorge TC, Miranda CF, De Souza W, Barbosa HS. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur J Cell Biol 1986; 41:198-206.
11. Pereira MC, Costa M, Chagas Filho C, Meirelles MN. Myofibrillar breakdown and cytoskeletal alterations in heart muscle cells during invasion by Trypanosoma cruzi: immunological and ultrastructural study. J Submicrosc Cytol Pathol 1993; 25:559-69.
12. Barbosa HS, Meirelles MN. Evidence of participation of cytoskeleton of heart muscle cells during the invasion of Trypanosoma cruzi. Cell Struct Funct 1995; 20:275-84.
13. Soeiro MN, Costa e Silva Filho F, Leal de Meirelles MN. Alterations in the surface charge of heart muscle cells during interaction with Trypanosoma cruzi. Cell Biophys 1995; 26:21-44.
14. Meirelles MN, Pereira MC, Singer RH, et al. Trypanosoma cruzi-cardiomyocytes: new contributions regarding a better understanding of this interaction. Mem Inst Oswaldo Cruz 1999; 94(Suppl 1):149-52.
15. 2+]i responses in primary cultures of mouse cardiomyocytes induced by Trypanosoma cruzi trypomastigotes. Mem Inst Oswaldo Cruz 2003; 98:487-93.
16. De Souza EM, Araujo-Jorge TC, Bailly C, et al. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res 2003; 314:223-35.
17. Garzoni LR, Caldera A, Meirelles MN, et al. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int J Antimicrob Agents 2004; 23:273-85.
18. Calvet CM, Meuser M, Almeida D, Meirelles MN, Pereira MC. Trypanosoma cruzi-cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo. Exp Parasitol 2004; 107:20-30.
19. De Castro SL, de Meirelles MN. Effect of drugs on Trypanosoma cruzi and on its interaction with heart muscle cell "in vitro". Mem Inst Oswaldo Cruz 1987; 82:209-18.
20. Teixeira AR, Nascimento RJ, Sturm NR. Evolution and pathology in Chagas disease- a review. Mem Inst Oswaldo Cruz 2006; 101:463-91.
21. Abbott A. Cell culture: biology's new dimension. Nature 2003; 424:870-2.
22. Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 2004; 22:195-202.
23. Kelm JM, Djonov V, Hoerstrup SP, et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng 2006; 12:2541-53.
24. Rossi MI, Barros AP, Baptista LS, et al. Multicellular spheroids of bone marrow stromal cells: a three-dimensional in vitro culture system for the study of hematopoietic cell migration. Braz J Med Biol Res 2005; 38:1455-62.
25. Weaver VM, Petersen OW, Wang F, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997; 137:231-45.
26. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res 2005; 97:1220-31.
27. Bertelli MS, Brener Z. Infection of tissue culture cells with bloodstream trypomastigotes of Trypanosoma cruzi. J Parasitol 1980; 66:992-7.
28. Rossi MA, Goncalves S, Ribeiro-dos-Santos R. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 1984; 114:209-16.
29. Soares MB, Pontes-De-Carvalho L, Ribeiro-Dos-Santos R. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Ciencias 2001; 73:547-59.
30. De Souza AP, Tang B, Tanowitz HB, Araujo-Jorge TC, Jelicks EL. Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol Res 2005; 97:87-90.
31. Petersen CA, Burleigh BA. Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infect Immun 2003; 71:4441-7.
32. Pinho RT, Vannier-Santos MA, Alves CR, Marino AP, Castello Branco LR, Lannes-Vieira J. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta Trop 2002; 83:103-15.
33. Unnikrishnan M, Burleigh BA. Inhibition of host connective tissue growth factor expression: a novel Trypanosoma cruzi-mediated response. FASEB J 2004; 18:1625-35.
34. Araujo-Jorge TC, Waghabi MC, Hasslocher-Moreno AM, et al. Implication of transforming growth factor-beta1 in Chagas disease myocardiopathy. J Infect Dis 2002; 186:1823-28.
35. Waghabi MC, Coutinho CM, Soeiro MN, et al. Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin. Infect Immun 2002; 70:5115-23.
36. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003; 116:3269-76.